STEFANIE GUNN: Open Payments
NPI 1114166501 · IRMO, SC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,641 in 152 payments from 23 companies in 2025. Trend: 2023 $2,045 · 2024 $3,657 · 2025 $2,641
Food & beverage: $2,641
| Company | Payments | Amount |
|---|---|---|
| Organogenesis Inc. | 4 | $332 |
| ABBVIE INC. | 24 | $252 |
| Novo Nordisk Inc | 13 | $235 |
| Otsuka America Pharmaceutical, Inc. | 11 | $232 |
| Amgen Inc. | 19 | $207 |
| AstraZeneca Pharmaceuticals LP | 9 | $186 |
| Corcept Therapeutics | 11 | $172 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 17 | $165 |
| Bayer Healthcare Pharmaceuticals Inc. | 7 | $152 |
| Abbott Laboratories | 8 | $120 |
Products named: REXULTI, Korlym, XIFAXAN, Kerendia, OTEZLA, Wegovy, NOVACHOR, AIRSUPRA.
Industry payments across SC — which companies pay providers there.
